ZeCardio Therapeutics (ZeCardioTx), a Barcelona based pharma company focused on the discovery of cardiovascular drugs using the zebrafish model and an innovative, proprietary screening and analysis platform, ZeCardio®, selected Taros Chemicals’ SVP Drug Discovery, Dr. Torsten Hoffmann, to join the…
The 17th edition of Annual Discovery on Target (DOT), the industry’s premier event for novel drug targets and technologies, will bring together more than 1,300 drug discovery experts from September 16 to 19, 2019 in Boston, Massachusetts USA. Target Validation Strategies for the Discovery and…
For nearly two decades, the BioJapan exhibition has played an pivotal role in promoting interaction between Japan and global organizations and in spuring new business opportunities. In October 2019, the world’s top business development, licensing and alliance management, R&D…
Dario Valenti, Stanimira Hristeva, Christian Ottmann, Anna Karawajczyk
We are transforming your ideas into products
We provide long-term value to our diverse customers through cutting-edge and innovative chemistry-based technologies
Taros creates holistic and cost-effective solutions of the highest quality and reliability for the global marketplace. We are inspired to provide exceptional value to our customers’ R&D processes, by anticipating hurdles, foreseeing cost and lead time reductions, thereby facilitating their competitive and “early to market” advantage. With our state-of-the-art lab facilities and our scientists (65% hold a Ph.D. in Chemistry) we are committed to serve the diverse needs of our customers in drug discovery, custom synthesis and specialty or performance chemicals. More than 13,000 synthesis, research and process chemistry projects have successfully been delivered to the ever-growing global customer base.